Mu et al. performed RNA-seq to uncover the expression profiling of lncRNAs in glioma tissue samples, and they found that lncRNA BCYRN1 serves as a tumor suppressor via inactivating the CUEDC2/PTEN/AKT/p21 pathway [55]. The gene discussed is AKT1; the disease is central nervous system cancer.